PRimary Care Opioid Use Disorders Treatment (PROUD) Trial

NACompletedINTERVENTIONAL
Enrollment

973,759

Participants

Timeline

Start Date

February 28, 2018

Primary Completion Date

February 29, 2020

Study Completion Date

February 29, 2020

Conditions
Opioid-use Disorder
Interventions
OTHER

PROUD Intervention

The PROUD intervention includes 3 strategies used to implement the MA Model: 1. Clinic leadership receives funding for a 1.0 full time equivalent NCM for 2 years after randomization and technical support for recruiting and hiring the NCM. Once hired for the study, the NCM will receive technical assistance (TA) from experts at Boston Medical Center (BMC) supported by PROUD, but NCMs will be employed and supervised by the health system. 2. Experts at BMC who originally developed and disseminated the MA Model will: provide intervention clinics with a Manual; train PROUD NCMs at BMC; and provide the ongoing TA for 2 years after randomization. 3. At least 3 primary care providers in the PROUD intervention clinic will obtain DEA waivers to prescribe buprenorphine for OUDs, if not already waivered, and work closely with the NCM to offer high quality primary care for OUDs (e.g. medication treatment with buprenorphine or naltrexone with close follow-up to maximize retention in treatment).

Trial Locations (6)

10467

Montefiore Medical Center, The Bronx

33136

University of Miami Health System, Miami

48202

Henry Ford Health System, Detroit

77054

Harris Health System, Houston

98112

Kaiser Permanente Washington, Seattle

98405

MultiCare Health System, Tacoma

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

The Emmes Company, LLC

INDUSTRY

lead

Kaiser Permanente

OTHER

NCT03407638 - PRimary Care Opioid Use Disorders Treatment (PROUD) Trial | Biotech Hunter | Biotech Hunter